This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Titan Medical Crecimiento futuro

Future controles de criterios 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Titan Medical.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	17.4%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Revenues Working Against Titan Medical Inc.'s (TSE:TMD) Share Price

Jan 09

There's No Escaping Titan Medical Inc.'s (TSE:TMD) Muted Revenues

Sep 25

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Titan Medical no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

TSX:TMD - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	0	-6	-6	-6	N/A
3/31/2024	18	9	5	5	N/A
12/31/2023	18	7	4	5	N/A
9/30/2023	18	-1	-3	-2	N/A
6/30/2023	17	-12	-9	-9	N/A
3/31/2023	N/A	-36	-28	-28	N/A
12/31/2022	N/A	-43	-29	-28	N/A
9/30/2022	10	-21	-33	-32	N/A
6/30/2022	10	-19	-35	-34	N/A
3/31/2022	20	-9	-26	-25	N/A
12/31/2021	20	-15	-37	-37	N/A
9/30/2021	20	-45	-25	-24	N/A
6/30/2021	20	-38	-19	-19	N/A
3/31/2021	20	-38	-12	-12	N/A
12/31/2020	20	-24	-1	-1	N/A
9/30/2020	10	-1	-3	-3	N/A
6/30/2020	10	-1	-10	-10	N/A
3/31/2020	N/A	-14	-30	-29	N/A
12/31/2019	N/A	-42	-46	-46	N/A
9/30/2019	N/A	-53	-62	-62	N/A
6/30/2019	N/A	-59	-62	-61	N/A
3/31/2019	N/A	-50	-55	-55	N/A
12/31/2018	N/A	-23	-42	-41	N/A
9/30/2018	N/A	-27	-29	-29	N/A
6/30/2018	N/A	-33	-24	-24	N/A
3/31/2018	N/A	-29	N/A	-21	N/A
12/31/2017	N/A	-34	N/A	-19	N/A
9/30/2017	N/A	-23	N/A	-17	N/A
6/30/2017	N/A	-11	N/A	-18	N/A
3/31/2017	N/A	-17	N/A	-21	N/A
12/31/2016	N/A	-23	N/A	-35	N/A
9/30/2016	N/A	-34	N/A	-42	N/A
6/30/2016	N/A	-44	N/A	-45	N/A
3/31/2016	N/A	-44	N/A	-46	N/A
12/31/2015	N/A	-41	N/A	-34	N/A
9/30/2015	N/A	-28	N/A	-29	N/A
6/30/2015	N/A	-20	N/A	-24	N/A
3/31/2015	N/A	-19	N/A	-18	N/A
12/31/2014	N/A	-13	N/A	-13	N/A
9/30/2014	N/A	-16	N/A	-10	N/A
6/30/2014	N/A	-15	N/A	-7	N/A
3/31/2014	N/A	-10	N/A	-8	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Insufficient data to determine if TMD's forecast earnings growth is above the savings rate (2.2%).

Beneficios vs. Mercado: Insufficient data to determine if TMD's earnings are forecast to grow faster than the Canadian market

Beneficios de alto crecimiento: Insufficient data to determine if TMD's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: Insufficient data to determine if TMD's revenue is forecast to grow faster than the Canadian market.

Ingresos de alto crecimiento: Insufficient data to determine if TMD's revenue is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Insufficient data to determine if TMD's Return on Equity is forecast to be high in 3 years time

This company is no longer active

Titan Medical Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Conavi Medical Corp. Appoints Thomas Looby as Chief Executive Officer

Titan Medical's Common Shares Expected to be Delisted from the Toronto Stock Exchange, Effective as of Close of Markets on or around October 16, 2024 upon Receipt of Final Approval of the TSX and the TSX-V

Titan Medical Inc. Announces Resignations of Directors

Titan Medical BoD Approves Voluntary Delisting of Common Shares from TSX

Titan Medical Inc., Annual General Meeting, Sep 30, 2024

Titan Medical Inc., Annual General Meeting, Sep 30, 2024

Conavi Medical Inc. entered into a definitive amalgamation agreement to acquire Titan Medical Inc. (TSX:TMD) in a reverse merger transaction.

Titan Medical Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Revenues Working Against Titan Medical Inc.'s (TSE:TMD) Share Price

New minor risk - Share price stability

New major risk - Market cap size

There's No Escaping Titan Medical Inc.'s (TSE:TMD) Muted Revenues

High number of new and inexperienced directors

Titan Medical Inc. Appoints Daniel O’Brien as A New Independent Member to Its Board of Directors

Titan Medical Inc. Announces Executive Terminations

Titan Medical Announces Receipt of Nasdaq Listing Determination

Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.077 loss in 3Q 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: US$0.09 loss per share (vs US$0.077 loss in 3Q 2021)

Titan Medical Inc. to Report Q3, 2022 Results on Nov 10, 2022

Titan Medical Inc. Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery

First half 2022 earnings released

High number of new and inexperienced directors

Titan Medical Inc. to Report Q2, 2022 Results on Aug 11, 2022

Titan Medical Inc. Announces Management Changes, Effective July 1, 2022

Titan Medical Gets 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Titan Medical Provides Update to Enos Project Timeline

Titan Medical Announces Departure of Perry Genova, Senior Vice President of Research and Product Development

Titan Medical Inc., Annual General Meeting, Jun 08, 2022

Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy

Titan Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Titan Medical Inc. has completed a Composite Units Offering in the amount of $20.004 million.

Titan Medical Inc. to Report Q4, 2020 Results on Feb 22, 2021

Titan Medical Inc. Provides Regulatory Update

Titan Medical Provides Update on Medtronic Development and License Agreement

Titan Medical Inc. Announces Board Appointments

Titan Medical Inc. Approves Election of Directors

Titan Medical Inc Announces the Launch of A New Name and Brand Identity for Its Robotic Surgical System Under Development

Titan Medical Confirms Receipt of Deficiency Notice from Nasdaq

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento